Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis
Open Access
- 1 January 2012
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2012, 1-10
- https://doi.org/10.1155/2012/626320
Abstract
Traditional Chinese medicine (TCM) syndrome, also called ZHENG, is the basis concept of TCM theory. It plays an important role in TCM practice. There are excess and deficiency syndromes in TCM syndrome. They are the common syndromes in chronic hepatitis B (CHB) patients. Here we aim to explore serum protein profiles and potential biomarkers for classification of TCM syndromes in CHB patients. 24 healthy controls and two cohorts of CHB patients of excess syndrome () or deficiency syndrome () were involved in this study. Protein profiles were obtained by surface-enhanced laser desorption ionization time-flight mass spectrometry (SELDI-TOF/MS) and multiple analyses were performed. Based on SELDI ProteinChip data, healthy controls and CHB patients or excess and deficiency syndromes in CHB patients were obviously differentiated by orthogonal partial least square (OPLS) analysis. Two significant serum proteins (m/z 4187 and m/z 5032) for classifying excess and deficiency syndromes were found. Moreover, the area under the receiver operating characteristic (ROC) curve was 0.887 for classifying excess and nonexcess syndrome, and 0.700 for classifying deficiency and nondeficiency syndrome, respectively. Therefore, the present study provided the possibility of TCM syndrome classification in CHB patients using a universally acceptable scientific approach.
Keywords
Funding Information
- National Science and Technology Major Project of China (2012ZX10005001-004, 2009ZX09311-003, J50301, E 03008)
This publication has 21 references indexed in Scilit:
- Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis BJournal of Pharmaceutical and Biomedical Analysis, 2012
- Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein MarkerAnnals of Surgical Oncology, 2010
- CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluidElectrophoresis, 2009
- Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysisWorld Journal of Gastroenterology, 2008
- High-Throughput Quantitative Profiling of Serum N-Glycome by MALDI-TOF Mass Spectrometry and N-Glycomic Fingerprint of Liver FibrosisClinical Chemistry, 2007
- Screening for biomarkers in plasma from patients with gangrenous and phlegmonous appendicitis using CE and CEC in combination with MSElectrophoresis, 2007
- A Proteomic Approach for the Diagnosis of ‘Oketsu’ (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) MedicineEvidence-Based Complementary and Alternative Medicine, 2007
- Therapeutic wisdom in traditional Chinese medicine: a perspective from modern scienceTrends in Pharmacological Sciences, 2005
- Variation in diagnosis and treatment of chronic low back pain by traditional Chinese medicine acupuncturistsComplementary Therapies in Medicine, 2001
- New desorption strategies for the mass spectrometric analysis of macromoleculesRapid Communications in Mass Spectrometry, 1993